| FAQs |
|
| Q-1. |
Where is Sun Pharma listed? |
|
|
Sun Pharma's equity shares are listed in demat mode on the major stock exchanges in India, the National Stock Exchange (with code SUNPHARMA) and Bombay Stock Exchange Ltd., Mumbai (code 524715). |
|
|
| Q-2. |
How can I buy Sun Pharma stock? |
|
|
You can place an order with a broker registered with SEBI. |
|
|
| Q-3. |
Where are Sun Pharma's corporate office and research centers located? |
|
|
Sun Pharma's corporate office is in Mumbai, India. One of the research centers is in Mumbai, and a large research campus is in Baroda, Gujarat, India. |
|
|
| Q-4. |
Why did Sun Pharma raise an FCCB? How much has been deployed? Where is the FCCB listed? When was the FCCB raised, why? What are the terms of the FCCB? |
|
|
Sun Pharma raised a $350 million, zero coupon FCCB in 2004, which are convertible at the option of the bondholder at a conversion price of Rs. 729.30 per share of Rs. 5 each at the fixed rate of conversion of Rs. 45.01= $1. If the bonds are not converted, they are to be redeemed after 5 years, on Nov 26, 2009 or in case of certain defined earlier exemptions at an accelerated premium of 4.61% p.a. with half yearly rests.
The company has an option to redeem the bonds any time after Nov 26, 2007 and prior to November 16, 2009. If all the FCCBs were converted, approx 21,600,850 equity shares of Rs. 5 each would have to be issued. The FCCB is listed on Singapore Exchange. The proceeds of the FCCB are earmarked for acquisitions in the US generic space. |
|
|
|
|
|
|
|
|
|
|
|
News Articles
Contact Us
